Sign In
Buy FMS
$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
Fresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis)
06:23am, Thursday, 27'th Oct 2022 Seeking Alpha
Fresenius Medical Care has been a long-term laggard in its industry, losing over 70% in the past 5 years. See how one can take advantage of FMS stock now.
Fresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis)
02:23am, Thursday, 27'th Oct 2022
Fresenius Medical Care has been a long-term laggard in its industry, losing over 70% in the past 5 years. The stock has seemingly bottomed and began to retrace on massive buy-side volume while breakin
Fresenius Medical (FMS) Robust Product Portfolio Drives Growth
04:07pm, Thursday, 25'th Aug 2022 Zacks Investment Research
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Fresenius Medical (FMS) Robust Product Portfolio Drives Growth
01:33pm, Thursday, 25'th Aug 2022
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
3 Dangerous Dividend Aristocrats To Avoid And 6 High-Yield Aristocrats To Buy Instead
11:00am, Saturday, 20'th Aug 2022 Seeking Alpha
EFAD, EUDV, and EMDV are three aristocratic ETFs that have delivered terrible inflation-adjusted returns. Check out our 6 high-yield aristocrats here.
Fresenius Medical's (FMS) Q2 Earnings Miss, Revenues Top
02:29pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Fresenius Medical's (FMS) second-quarter earnings benefit from strong performance across all the geographic regions and segments. However, rising costs hurt margins.
Fresenius Medical's (FMS) Q2 Earnings Miss, Revenues Top
12:05pm, Tuesday, 02'nd Aug 2022
Fresenius Medical's (FMS) second-quarter earnings benefit from strong performance across all the geographic regions and segments. However, rising costs hurt margins.
Fresenius Medical Care: Best Time In 21 Years To Buy This High-Yield Dividend Aristocrat
11:00am, Saturday, 30'th Jul 2022 Seeking Alpha
Fresenius isn't just an undervalued aristocrat, it's a company and stock that could present strong returns in the next five years.
Fresenius Medical Care: Best Time In 21 Years To Buy This High-Yield Dividend Aristocrat
07:00am, Saturday, 30'th Jul 2022
Fresenius isn't just an undervalued aristocrat, it's a Buffett-style anti-bubble "fat pitch" that could deliver 235% returns in the next five years. Even with the Pandemic-induced downturn, FMS is exp
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
09:55am, Friday, 29'th Jul 2022 Benzinga
Gainers
Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 20
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
04:41pm, Thursday, 28'th Jul 2022 Benzinga
Gainers
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 231% to $2.63 on news that the company will be acquired By Henry Crown and Company for $3.25 per share. Petros Pharmaceuticals, however, con
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday
03:45pm, Thursday, 28'th Jul 2022 Benzinga
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan.
Pathward Financial, Inc. (NASDAQ: CASH) fell 25.2% to $32.26
Why Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving Premarket
10:09am, Thursday, 28'th Jul 2022 Benzinga
Gainers
JAKKS Pacific, Inc. (NASDAQ: JAKK) rose 34.7% to $23.01 in pre-market trading after the company reported better-than-expected Q2 results.
Athersys, Inc. (NASDAQ: ATHX) rose 35.1% to $0.2568 i
Fresenius now expects lower revenue, earnings in the second half, citing wage inflation and staff shortages in North America
08:13am, Thursday, 28'th Jul 2022
Shares of Fresenius Medical Care tumbled 13.7% in premarket trading on Thursday after telling investors to expect lower-than-expected revenue and net income in the second half of the year. The company
2 High-Yield Dividend Aristocrats Potentially Set To Soar And 10 You Should Ignore
01:15pm, Saturday, 23'rd Jul 2022 Seeking Alpha
Dividends are an essential part of achieving life-changing wealth in the stock market. Click here for 2 high-yield dividend aristocrats potentially set to soar.
